Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
- 30 April 1995
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 129 (2) , 147-151
- https://doi.org/10.1016/0022-510x(94)00266-q
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, BrazilActa Neurologica Scandinavica, 2009
- Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)Arquivos de Neuro-Psiquiatria, 1993
- Spastic paraparesis of obscure originJournal of the Neurological Sciences, 1993
- Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP)Journal of the Neurological Sciences, 1990
- Rapid Development of Myelopathy after HTLV-I Infection Acquired by Transfusion during Cardiac TransplantationNew England Journal of Medicine, 1990
- Methylprednisolone therapy in tropical spastic paraparesis.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Immunological findings in neurological diseases associated with antibodies to HTLV-I: Activated lymphocytes in tropical spastic paraparesisAnnals of Neurology, 1988
- Intrathecal synthesis of IgG antibodies to HTLV-I supports an etiological role for HTLV-I in tropical spastic paraparesisAnnals of Neurology, 1988
- HTLV-1 Infection in Tropical Spastic Paraparesis: Lymphocyte Culture and Serologic ResponseAIDS Research and Human Retroviruses, 1988
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISPublished by Elsevier ,1985